Riemser Pharma Overview
- Year Founded
-
1992
- Status
-
Acquired/Merged
- Employees
-
234
- Latest Deal Type
-
M&A
- Financing Rounds
-
7
- Investments
-
6
Riemser Pharma General Information
Description
Distributor of specialty pharmaceuticals intended to treat special medical conditions for which there is a high unmet medical need. The company's distribution and life-cycle management services are focused in therapeutic niche areas with high, unmet needs such as oncology and rheumatology, infectiology, dermatology and cardiovascular diseases, enabling pharmaceutical companies to tap new markets of specialty pharmaceuticals, extend product life cycles and increase profitability.
Contact Information
Website
www.riemser.comCorporate Office
- An der Wiek 7
- 17493 Greifswald
- Germany
Corporate Office
- An der Wiek 7
- 17493 Greifswald
- Germany
Riemser Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Riemser Pharma Comparisons
Industry
Financing
Details
Riemser Pharma Competitors (1)
One of Riemser Pharma’s competitors is Midas Pharma, a Corporation company based in Ingelheim, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Midas Pharma | Corporation | Ingelheim, Germany |
Riemser Pharma Signals
Riemser Pharma Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Riemser Pharma Investments (6)
Riemser Pharma’s most recent deal was a Buyout/LBO with Zaltanpharma. The deal was made on 02-Oct-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Zaltanpharma | 02-Oct-2019 | Buyout/LBO | Media and Information Services (B2B) | ||
| Dolorgiet (CNS portfolio) | 05-Sep-2016 | Buyout/LBO | Buildings and Property | ||
| Intrapharm Laboratories | 16-Nov-2015 | Buyout/LBO | Pharmaceuticals | ||
| Keocyt | 12-May-2014 | Buyout/LBO | Pharmaceuticals | ||
| Anwerina Deutschland | 23-Apr-2012 | Corporate | Pharmaceuticals |
Riemser Pharma Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Fatol Arzneimittel | Schiffweiler, Germany | 2008 |
Riemser Pharma FAQs
-
When was Riemser Pharma founded?
Riemser Pharma was founded in 1992.
-
Where is Riemser Pharma headquartered?
Riemser Pharma is headquartered in Greifswald, Germany.
-
What is the size of Riemser Pharma?
Riemser Pharma has 234 total employees.
-
What industry is Riemser Pharma in?
Riemser Pharma’s primary industry is Distributors (Healthcare).
-
Is Riemser Pharma a private or public company?
Riemser Pharma is a Private company.
-
What is the current valuation of Riemser Pharma?
The current valuation of Riemser Pharma is .
-
What is Riemser Pharma’s current revenue?
The current revenue for Riemser Pharma is .
-
How much funding has Riemser Pharma raised over time?
Riemser Pharma has raised $77.3M.
-
Who are Riemser Pharma’s investors?
Ardian France, NORD Holding, SLR Life Science Finance, and TVM Capital have invested in Riemser Pharma.
-
Who are Riemser Pharma’s competitors?
Midas Pharma is a competitor of Riemser Pharma.
-
When was Riemser Pharma acquired?
Riemser Pharma was acquired on 25-Feb-2020.
-
Who acquired Riemser Pharma?
Riemser Pharma was acquired by Esteve Healthcare.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process